Forum Programme - OPHTHALMOLOGY...Frederic Guerard (Novartis) Rafiq Hassan (Bayer) Eugene de Juan (ForSight Labs) Ram Palanki (Regenxbio) Einar Stéansson (University of Iceland) Ramin

Vienna 2018

Forum Programme

Wednesday 19 September

Retina Forum, ViennaHilton Danube Waterfront Hotel

Ophthalmology Futures Retina Forum 2018 Vienna2

> 15:45 – 16:15

Registration and Coffee

> 16:15 – 16:20

Welcome from the Co-chairsCo-chairs

Keith Barton (Moorfields Eye Hospital) Kuldev Singh (Stanford University Medical Center).

> 16:20 – 16:55

Why is Retina so Exciting to Investors?Chair

Naveed Siddiqi (Andera Partners).

Panellists

Yuval Binur (Arsuf Global Parnters) Michael Giaquinto (Leerink Partners) Eugene de Juan (ForSight Labs) Richel Liu (Rimonci Capital) Florian Muellershausen (Novartis Venture Fund).

> 16:55 – 17:20

Company Presentations 116:55 – 17:02 REGENXBIO, Inc.

(Ken Mills, CEO)

17:02 – 17:09 Nightstar Therapeutics, Inc. (Tuyen Ong, CDO)

17:09 – 17:16 Ora, Inc. (Keith Lane, Senior Director, R&D)

17:16 – 17:20 Summary

> 17:20 – 17:55

Gene Replacement Vs Protein Therapy for Retinal Disease: Targets, Challenges and Business StategiesChair

Pravin Dugel (Retinal Consultants of Arizona Ltd).

Panellists

Simon Chandler (Ora) Thomas Ciulla (Spark Therapeutics) Dominik Fischer (University of Tübingen) Ken Mills (Regenxbio) Tuyen Ong (Nightstar Therapeutics) Dirk Sauer (Novartis) Baldo Sforzolini (Allergan).

> 17:55 – 18:25

Microinstrumentation for Vitreoretinal Surgery: Is it All About Size?Co-chairs

Paulo Stanga (University of Manchester) Ramin Tadayoni (Université Paris 7).

Panellists

Borja Corcóstegui (Institut de Microcirurgia Ocular) Paul Hallen (Alcon) Rob Niemeitz (Bausch+Lomb) Marc de Smet (Preceyes) Rodrigo Zapiain (Cambridge Consultants). .

Retina Forum 2018 programmeSpeakers' affiliations can be found on the inside back cover.

Ophthalmology Futures Retina Forum 2018 Vienna 3

> 18:25 – 19:10

Company Presentations 218:25 – 18:32 Preceyes BV

(Gerrit Naus, CEO)

18:32 – 18:39 Aerie Pharmaceuticals, Inc. (Theresa Heah, Vice-President)

18:39 – 18:46 Re-Vana Therapeutics (Michael O’Rourke, CEO)

18:46 – 18:53 2C Tech (Jim Taylor, CEO)

18:53 – 19:00 Aerpio Therapeutics (Steve Pakola, CMO)

19:00 – 19:10 Summary

> 19:10 – 19:40

Fewer Injections Better Outcomes with Anti VEGF – Can You Have Your Cake and Eat It?Co-chairs Francesco Bandello (University Vita-Salute) Anat Loewenstein (Sackler Faculty of Medicine).

Panellists

Andrzej Grzybowski (University of Warmia) Frederic Guerard (Novartis) Rafiq Hassan (Bayer) Eugene de Juan (ForSight Labs) Ram Palanki (Regenxbio) Einar Stéansson (University of Iceland) Ramin Tadayoni (Université Paris 7).

> 19:40 – 20:10

Artificial Intelligence?Co-chairs

Ursula Schmidt-Erfurth (Medical University Vienna) Adnan Tufail (Moorfields Eye Hospital).

Panellists

Almira Chabi (Santen) Pearse Keane (Moorfields Eye Hospital) Jai Parekh (Allergan) Angelo Rago (Carl Zeiss Meditec) Dirk Sauer (Novartis).

> 20:10 – 20:20

SummaryChair

Adnan Tufail (Moorfields Eye Hospital).

> 20:20 – 20:25

Concluding Remarks from the Co-chairsCo-chairs

Keith Barton (Moorfields Eye Hospital) Kuldev Singh (Stanford University Medical Center).

> 20:25 – 21:00

Cocktail Reception